On February 25, 2015, a memorandum of law with respect to disclosure statement with respect to a plan of reorganization or liquidation was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1178 and is described on the court’s official docket as follows:
Joint Brief/Memorandum of the Chapter 11 Trustee and the Official Committee of Unsecured Creditors Submitting Certain Authorities In Support of the Plan Proponents’ Joint Motion to Approve the Disclosure Statement (Re:  Motion to Approve) filed by Trustee Paul D. Moore (Johnson, Stephen)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.